Is 2-FDCK legal in United Arab Emirates?

Legal status

2-FDCK is placed at Schedule 6, item 3 of Decision No. 158 of 2025, the printed entry being «2-فلورو ديسكلوروكيتامين», and the dossier records that the schedule reaches it by its expanded name and chemical formula, rendering the chemical name as 2-(2-fluorophenyl)-2-(methylamino)cyclohexanone. The fluorine for chlorine substitution is the entire basis on which this compound is sold as distinct from ketamine, and the schedule has answered it by printing the fluoro compound in its own right at item 3 rather than leaving it to be argued into the ketamine entry at item 7 of the same schedule. So the two arylcyclohexylamines sit four items apart in the same schedule, each named. The row runs through Articles 11, 43 and 58, with Schedule 10 group 3 carrying the quantity band. The placement was read on 20 September 2026.

Consequences if caught

Article 58 reaches Schedules 3, 6, 7 and 8, and this compound is at Schedule 6, item 3, so the article applies to the row. The dossier records Article 58 as providing death or life imprisonment as alternatives for its stated trafficking or promotion trigger, so death is discretionary on this row rather than mandatory, which is the specific respect in which the Schedule 6 branch differs from the Schedule 1, 2, 4 Section I and 5 branch. The article states no quantity, and the Schedule 10 group 3 band that applies to this substance does not gate it. A capital route that is discretionary and quantity free is still a capital route, and neither the discretion nor the group 3 figure should be read as a threshold below which it disappears. Article 43 carries the personal use route for this branch, with no tariff stated.

If prescribed or medical

The dossier records at the modafinil row that a 268 entry ministry travellers list was checked and expressly not used as a schedule. Attached to this substance: 2-FDCK is at Schedule 6, item 3, a research chemical placement with no medicinal product behind it, in contrast to the ketamine entry at item 7 of the same schedule which does have a clinical use. No prescribing route or permit is recorded for it, so the medical question is deferred rather than borrowed from the neighbouring entry.

Documentation

No documentation route is recorded for 2-FDCK. Provenance: the entry «2-فلورو ديسكلوروكيتامين» at Schedule 6, item 3 was read on 20 September 2026, with the capital analysis resting on Article 58 and its death or life alternative rather than on the Schedule 10 group 3 band. The practical point is that the fluoro compound has its own item number, so a vendor's claim that it is not the scheduled anaesthetic is correct and irrelevant.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with United Arab Emirates’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.